This Is MS Multiple Sclerosis Knowledge & Support Community

Posted: **Thu Jan 27, 2011 9:23 am**

Receptos Initiates Clinical Trials for S1P1 Agonist Program, Aimed at Multiple Sclerosis <shortened url>

Posted: **Thu Jan 27, 2011 3:22 pm**

Sounds a lot like Gilenya.

Posted: **Thu Jan 27, 2011 8:26 pm**

Thanks for the info Scorpion. I agree patientx. I don't know if that's good or bad. On the bright side, it appears to be a worthwhile target. On the other hand, is there any reason to believe this will be better than gilenya?

Posted: **Thu Jan 27, 2011 10:03 pm**

If nothing else, maybe it will reduce the price gouging going on.